Literature DB >> 14656483

Controlling cell fate by bone morphogenetic protein receptors.

Peter ten Dijke1, Olexander Korchynskyi, Gudrun Valdimarsdottir, Marie-José Goumans.   

Abstract

Bone morphogenetic proteins (BMPs) are multifunctional proteins that regulate the fate of different cell types, including mesenchymal and endothelial cells. BMPs inhibit myogenic differentiation, but promote the differentiation of mesenchymal cells into osteoblasts. Furthermore, endothelial migration and tube formation are stimulated by BMPs. Like other members of the transforming growth factor-beta (TGF-beta) superfamily, BMPs elicit their cellular effects via specific types I and II serine/threonine receptors. The activated BMP type I receptor phosphorylates specific receptor-regulated (R)-Smad proteins, which assemble into heteromeric complexes with common partner (Co)-Smad4. Heteromeric Smad complexes efficiently translocate into the nucleus, where they regulate the transcription of target genes. Inhibitors of differentiation (Id) are genes that are specifically induced by BMPs in tissues of different origin. Promoter analysis of Id1 indicates three distinct sequence elements that are sufficient and essential for efficient BMP-induced activation. Furthermore, recent studies reveal an important effector function for Id1 in various BMP-induced biological responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14656483     DOI: 10.1016/j.mce.2003.09.016

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  63 in total

1.  Genome-scale study of transcription factor expression in the branching mouse lung.

Authors:  John C Herriges; Lan Yi; Elizabeth A Hines; Julie F Harvey; Guoliang Xu; Paul A Gray; Qiufu Ma; Xin Sun
Journal:  Dev Dyn       Date:  2012-07-20       Impact factor: 3.780

Review 2.  Recent advances in the application of mesoporous silica-based nanomaterials for bone tissue engineering.

Authors:  Reza Eivazzadeh-Keihan; Karim Khanmohammadi Chenab; Reza Taheri-Ledari; Jafar Mosafer; Seyed Masoud Hashemi; Ahad Mokhtarzadeh; Ali Maleki; Michael R Hamblin
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2019-10-15       Impact factor: 7.328

3.  Germline mutations in SMAD4 disrupt bone morphogenetic protein signaling.

Authors:  Jennifer C Carr; Fadi S Dahdaleh; Donghong Wang; James R Howe
Journal:  J Surg Res       Date:  2011-11-30       Impact factor: 2.192

4.  Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases.

Authors:  Ruth Schwaninger; Cyrill A Rentsch; Antoinette Wetterwald; Geertje van der Horst; Rutger L van Bezooijen; Gabri van der Pluijm; Clemens W G M Löwik; Karin Ackermann; Walter Pyerin; Freddie C Hamdy; George N Thalmann; Marco G Cecchini
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

5.  Smad signaling in the neural crest regulates cardiac outflow tract remodeling through cell autonomous and non-cell autonomous effects.

Authors:  Qunshan Jia; Bradley W McDill; Song-Zhe Li; Chuxia Deng; Ching-Pin Chang; Feng Chen
Journal:  Dev Biol       Date:  2007-08-31       Impact factor: 3.582

6.  Expression of Id1 in adult, regenerating and developing pancreas.

Authors:  Hong Hua; Nora Sarvetnick
Journal:  Endocrine       Date:  2008-03-06       Impact factor: 3.633

7.  Bmp4 is required for tracheal formation: a novel mouse model for tracheal agenesis.

Authors:  Yina Li; Julie Gordon; Nancy R Manley; Ying Litingtung; Chin Chiang
Journal:  Dev Biol       Date:  2008-07-26       Impact factor: 3.582

8.  Skin keratinocytes pre-treated with embryonic stem cell-conditioned medium or BMP4 can be directed to an alternative cell lineage.

Authors:  K L Grinnell; J R Bickenbach
Journal:  Cell Prolif       Date:  2007-10       Impact factor: 6.831

9.  Systematic comparison of gene expression between murine memory and naive B cells demonstrates that memory B cells have unique signaling capabilities.

Authors:  Mary M Tomayko; Shannon M Anderson; Catherine E Brayton; Saheli Sadanand; Natalie C Steinel; Timothy W Behrens; Mark J Shlomchik
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

10.  The correlation of bone morphogenetic protein 2 with poor prognosis in glioma patients.

Authors:  Xiangshan Yang; Daotang Li; Shaomei Cheng; Kaixi Fan; Lijun Sheng; Jing Zhang; Bin Feng; Zhongfa Xu
Journal:  Tumour Biol       Date:  2014-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.